Beta Cell Function in (Pre)Type 1 Diabetes
Relation Between Residual Beta Cell Function and Glycemic Variability in (Pre) Type 1 Diabetes.
Sponsor: AZ-VUB
Listed as NCT01402037, this NA trial focuses on Type 1 Diabetes and remains ongoing. Sponsored by AZ-VUB, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AZ-VUB
- University Hospital, Antwerp
- University Hospital, Ghent
- Vrije Universiteit Brussel
For direct contact, visit the study record on ClinicalTrials.gov .